Bioengineered, tunable sensors that are designed for each protease-mediated disease.
Indications | Discovery | Preclinical | Phase 1 | Phase 2 | Phase 3 |
---|---|---|---|---|---|
Fibrotic Diseases | |||||
Non-Alcoholic Steatohepatitis (NASH) |
|
||||
Other Fibrotic Diseases |
|
||||
Oncology | |||||
Non Small Cell Lung Cancer (NSCLC) |
|
||||
Other Solid Tumors |
|
||||
Infectious Disease | |||||
Undisclosed |
|